You have 9 free searches left this month | for more free features.

City

Stanford (1)

Condition

Graft Versus Host Disease (1)

Non-small Cell Lung Cancer (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

CellSight Technologies, Inc. (1)

University of California, San Francisco (1)

Collaborator

CellSight Technologies, Inc. (1)

Stanford University (1)

Intervention

[18f]f-ara-g (2)

pembrolizumab (1)

pet/ct scan (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

[18f]f-ara-g

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GVHD Trial in Stanford ([18F]F-Ara-G)

Recruiting

Graft Versus Host Disease

[18F]F-Ara-G

Stanford, California

Stanford Hospital

Mar 7, 2022

NSCLC Trial ([18F]F-Ara-G, Pembrolizumab, PET/CT scan)

Withdrawn

Non-small Cell Lung Cancer

[18F]F-Ara-G
+2 more

(no location specified)

Oct 17, 2019